Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Benazepril in Diabetic Nephropathy
NCT00171119Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jan 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of valsartan in diabetic nephropathy (DN) (3 arms), sponsored by Novartis. Primary endpoint: Change from baseline in urine albumin excretion rate at 24 weeks. Started Jan 2004; status: terminated.
02
Drugs
valsartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00171119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171119.